AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find Radio Compass News for Famotidine

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
101
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218461

FDA
14 Mar 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf

FDA
24 Jan 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217605

FDA
16 Jan 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217669

FDA
20 Dec 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217330

FDA
17 Aug 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-26-2023-55742.pdf

FDA
26 Jul 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217137

FDA
07 Jul 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217655

FDA
16 Jun 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/marksans-pharma-gets-final-usfda-nod-for-generic-version-of-famotidine-tablets/articleshow/98538255.cms

ECONOMIC TIMES
10 Mar 2023

https://www.indianpharmapost.com/news/zydus-receives-final-approval-from-usfda-for-famotidine-injection-13334

INDIANPHARMAPOST
24 Nov 2022

https://www.fiercepharma.com/pharma/opening-round-zantac-litigation-gsk-scores-decisive-win

Kevin Dunleavy FIERCEPHARMA
17 Aug 2022

https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-sanofi-haleon-shares-stabilise-after-zantac-litigation-slump-2022-08-12/

Natalie Grover REUTERS
12 Aug 2022

https://www.businesswire.com/news/home/20220811005562/en/Amneal-launches-4-new-Generic-products-including-Vasopressin-single-dose

BUSINESSWIRE
11 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216427

FDA
04 Aug 2022

https://www.expresspharma.in/zydus-lifesciences-receives-final-approval-from-us-fda-for-famotidine-tablets/

EXPRESS PHARMA
06 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216441

FDA
03 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216441

FDA
03 Jun 2022

https://www.pharmacytimes.com/view/camber-pharma-launches-generic-pepcid-

PHARMACYTIMES
02 Jun 2022

https://www.businesswire.com/news/home/20220519005835/en

BUSINESSWIRE
19 May 2022

https://www.businesswire.com/news/home/20220210005964/en

BUSINESSWIRE
10 Feb 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215822

FDA
28 Jan 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215630

FDA
07 Jan 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215766

FDA
15 Nov 2021